Back to NVSEF
Franklin, Parlapiano, Turner & Welch, LLC → NVSEF
Franklin, Parlapiano, Turner & Welch, LLC NVSEF Position History
Novartis AG
Quarters held
4
Latest value
$8.8M
Q3 2026
Peak value
$10.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $10.2M |
| Q1 2026 | $9.6M |
| Q2 2026 | $9.9M |
| Q3 2026 | $8.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.8M | 61.4K | — | — |
| Q2 2026 | $9.9M | 63.4K | — | — |
| Q1 2026 | $9.6M | 65.1K | — | — |
| Q4 2025 | $10.2M | 70.5K | — | — |
Other funds holding NVSEF
$1.9B
$1.7B
$1.7B
$1.4B
$1.4B
$1.3B
Other Franklin, Parlapiano, Turner & Welch, LLC positions
VGES
$74.4MVANGUARD S&P 500 ETF
VGES
$74.3MVANGUARD S&P 500 ETF
VGES
$72.7MVANGUARD S&P 500 ETF
VGES
$71.9MVANGUARD S&P 500 ETF
VGES
$47MVANGUARD FTSE DEVELOPED MARKETS ETF
ETHA
$45.2MISHARES FTSE NAREIT RESID PLUS CP IDX
ETHA
$42.2MISHARES FTSE NAREIT RESID PLUS CP IDX
ETHA
$41.4MISHARES FTSE NAREIT RESID PLUS CP IDX